Prevalence of underlying lung disease in smokers with epidermal growth factor receptor-mutant lung cancer

By                        

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 2005-2010

Spandidos Publications

Access to resources Recommend Favorite

Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics

By Motoshima Kohei   Nakamura Yoichi   Sano Kazumi   Ikegami Yoji   Ikeda Takaya   Mizoguchi Kosuke   Takemoto Shinnosuke   Fukuda Minoru   Nagashima Seiji   Iida Tetsuya   Tsukamoto Kazuhiro   Kohno Shigeru  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1299-1304

Springer Publishing Company

Access to resources Recommend Favorite

Cerebral venous sinus thrombosis concomitant with leptomeningeal carcinomatosis, in a patient with epidermal growth factor receptormutated lung cancer

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2489-2492

Spandidos Publications

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Signaling in Nonsmall Cell Lung Cancer

By Ganti Apar Kishor  

Cancer Investigation, Vol. 28, Iss. 5, 2010-05 ,pp. : 515-525

Informa Healthcare

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibitors: A New Prospective in the Treatment of Lung Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 2, 2004-03 ,pp. : 139-148

Bentham Science Publishers

Access to resources Recommend Favorite